Canadian Acquisitions: QLT Inc. Fits the Trend
Research - It seems QLT Inc. may be on the block after a press release on Wednesday evening indicated the company has engaged Credit Suisse as a … Continue Reading
Read nowSearch Results for endo health
No News for QLTI, Yet the Stock is Going
Research - Note: This article was sent to PropThink Premium members during the afternoon of November 20, 2013. Also see our follow-up commentary here. In morning trading, … Continue Reading
Premium
The Long Case for Zogenix
Research - Zogenix (ZGNX) expects to net $56 million from a secondary offering revealed on November 4, $64.4 million with full exercise of the underwriter’s over-allotment option. … Continue Reading
Read nowPropThink’s Biotech Roundup: A Few Stories from the Week
Recap - Endo Health Solutions (ENDP) announced plans on Tuesday to purchase Paladin Labs (PLB.TO), a Canadian specialty pharmaceutical manufacturer, for $1.5 billion. ENDP fell significantly in 2012 on … Continue Reading
Read nowBioDelivery Sciences’ Debt Deal Puts Inflection Points Within Range
Long Ideas - BioDelivery Sciences (BDSI) on Monday entered into a $20 million senior secured loan with MidCap Financial and issued to the group a warrant to purchase … Continue Reading
Read nowEight Trade Ideas and A Recap of our Latest
Most Popular - Vascepa’s commercial prospects are one of the hottest topics of debate in biotechnology, and this week PropThink outlined why you can trade Amarin (AMRN) in … Continue Reading
Read nowThe Wrap-Up: PropThink’s Top Picks this Week
Long Ideas - ResMed (RMD) is suing a new and low-cost competitor in the Continues Positive Airway Pressure market. The target, 3B Medical, isn’t taking the litigation lying … Continue Reading
Read now